Literature DB >> 3280126

Recent advances in drug delivery technology for neurology.

S M Stahl1, K M Wets.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 3280126     DOI： 10.1097/00002826-198802000-00001

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN： 0362-5664            Impact factor:   1.592


× No keyword cloud information.
  5 in total

1.  (+)-PHNO: a new anti-parkinsonian agent which does not induce chorea in MPTP-treated squirrel monkeys.

Authors:  N M Rupniak; S Boyce; M J Steventon; S D Iversen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-07       Impact factor: 10.154

2.  Behavioural effects of (+)-4-propyl-9-hydroxynaphthoxazine in primates rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Authors:  C E Clarke; S Boyce; M A Sambrook; S M Stahl; A R Crossman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-07       Impact factor: 3.000

3.  Therapeutic efficacy of a novel transdermal delivery system for (+)-PHNO in parkinsonian squirrel monkeys.

Authors:  N M Rupniak; S J Tye; C A Jennings; A E Loper; J V Bondi; M Hichens; S D Iversen; S M Stahl
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

Review 4.  Transdermal treatment options for neurological disorders: impact on the elderly.

Authors:  Lorenzo Priano; Maria Rosa Gasco; Alessandro Mauro
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 5.  Potential of transdermal drug delivery in Parkinson's disease.

Authors:  Ronald F Pfeiffer
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.